Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9801865
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
granted -
US 9801911
Expansion of alloantigen-reactive regulatory T cells
granted -
US 9801938
Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
granted -
US 9802904
Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof
granted -
US 9803022
Mesothelin domain-specific monoclonal antibodies and use thereof
granted -
US 9801945
Long-acting polymeric delivery systems
granted -
US 9804163
Biomarkers for prostate cancer and methods for their detection
granted -
US 9801848
Prevention of rosacea inflammation
granted -
US 9802942
Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
granted -
US 9801962
Radioactive nanoparticles and methods of making and using the same
granted -
US 9803187
Baulamycins, compositions and methods of use thereof
granted -
US 9803205
Compositions and methods for inhibiting gene expression of factor XII
granted -
US 9803201
Disulfide-containing alkyne linking agents
granted -
US 9803202
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted -
US 9803194
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 9803021
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
granted -
US 9802949
Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
granted -
US 9802946
NMDA receptor modulators and uses thereof
granted -
US 9802927
Oxadiazine compounds and methods of use thereof
granted -
US 9801952
Magnetic nanostructures as theranostic agents
granted -
US 9801954
Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression
granted -
US 9801944
Lipocationic polymers and uses thereof
granted -
US 9801942
Etanercept formulations stabilized with metal ions
granted -
US 9801934
Parenteral norovirus vaccine formulations
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.